Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

58.88
Delayed Data
As of Mar 24
 +0.20 / +0.34%
Today’s Change
30.00
Today|||52-Week Range
62.50
+5.94%
Year-to-Date
Alkermes Starts Phase III Study to Treat Multiple Sclerosis
Mar 17 / Zacks.com - Paid Partner Content